[Congressional Record (Bound Edition), Volume 163 (2017), Part 9]
[Extensions of Remarks]
[Page 13371]
[From the U.S. Government Publishing Office, www.gpo.gov]




  PEER-REVIEWED PROSTATE CANCER RESEARCH IN THE DEPARTMENT OF DEFENSE 
                        APPROPRIATIONS ACT, 2018

                                 ______
                                 

                            HON. DARREN SOTO

                               of florida

                    in the house of representatives

                      Wednesday, September 6, 2017

  Mr. SOTO. Mr. Speaker, Soto amendment, Soto number 20 to Division A, 
the Department of Defense Appropriations Act, 2018, moved $10 million 
from the Operation and Maintenance, Defense-Wide account to the Defense 
Health Program's Peer-Reviewed Prostate Cancer Research Program.
  Prostate cancer is the most commonly diagnosed cancer in men and is 
the second most common cause of male death. In 2017, approximately 
161,360 men in the U.S. will be diagnosed with prostate cancer and an 
estimated 26,730 will die from it.
  The Prostate Cancer Research Program is a unique research program in 
that it prioritizes research that will lead to the elimination of death 
from prostate cancer while enhancing the well-being of men experiencing 
the impact of the disease.
  I support funding prostate cancer research and thank my colleagues 
for their support of my amendment.

                          ____________________